A Phase I, Open-label, Dose-escalation Study to Assess the Safety and Tolerability of AZD0530 in Patients With Advanced Solid Malignancies
A Phase I, Open-label, Dose-escalation Study to Assess the Safety and Tolerability of AZD0530 in Patients With Advanced Solid Malignancies
This is a dose escalation study to assess the safety and tolerability of AZD0530 in patients with advanced solid malignancies.
Inclusion Criteria:
Exclusion Criteria:
Takatsuk, Osaka, Japan
Sunto-gun, Shizuoka, Japan